Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026
Go back to Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 266.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.11 | 52 Week High | $109.10 | |||
| Open | $266.11 | 52 Week Low | $31.38 | |||
| Day High | $266.11 | P/E | N/A | |||
| Day Low | $266.11 | EPS | $-1.45 | |||
| Volume | 8,162 | |||||
